Characteristics and survival of 26 patients with paraneoplastic arthritis.

Paraneoplastic rheumatic syndromes: report of eight cases and review of literature. Rheumatol Int (2011) 0.93

Whole-Body (18) FDG-PET in an Arthritis Paraneoplastic Syndrome Revealed an Underlying Hematological Neoplasm. Case Rep Med (2013) 0.86

Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours. Clin Rheumatol (2011) 0.83

Musculoskeletal manifestations in patients with malignant disease. Clin Rheumatol (2009) 0.78

Report of anti-CCP antibody positive paraneoplastic polyarthritis and review of the literature. Rheumatol Int (2009) 0.76

Migrating Polyarthritis as a Feature of Occult Malignancy: 2 Case Reports and a Review of the Literature. Case Rep Oncol Med (2015) 0.75

Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica. Rheumatol Int (2016) 0.75

[Tibial pain and unilateral knee arthritis: Precursors of paraneoplastic arthropathy]. Z Rheumatol (2011) 0.75

Relation between income inequality and mortality in Canada and in the United States: cross sectional assessment using census data and vital statistics. BMJ (2000) 5.11

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis (2003) 3.33

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum (2009) 2.92

Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet (1999) 2.79

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)). Ann Rheum Dis (2010) 2.68

High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial. Blood (1998) 2.62

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55

Assessing ecologic proxies for household income: a comparison of household and neighbourhood level income measures in the study of population health status. Health Place (1999) 2.54

Piriformis muscle syndrome: diagnostic criteria and treatment of a monocentric series of 250 patients. Ann Phys Rehabil Med (2013) 2.19

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06

Focal myositis: a localized form of polymyositis? J Rheumatol (1993) 2.05

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study. Arthritis Rheum (2006) 1.96

SAPHO syndrome: a followup study of 19 cases with special emphasis on enthesis involvement. J Rheumatol (1995) 1.94

Cost of combined modality interventions for stage III non-small-cell lung cancer. J Clin Oncol (1997) 1.82

T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med (1996) 1.80

Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66

Body mass index and incidence of dementia: the PAQUID study. Neurology (2003) 1.63

Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum (1993) 1.63

Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61

Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer (2000) 1.61

Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis (2010) 1.61

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59

Age-specific education and income gradients in morbidity and mortality in a Canadian province. Soc Sci Med (1997) 1.55

Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum (2001) 1.52

Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol (2008) 1.52

The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies. Arthritis Rheum (2000) 1.51

Laparoscopic adjustable gastric banding. World J Surg (1998) 1.48

Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood (1997) 1.48

Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model. Can J Oncol (1995) 1.47

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum (2010) 1.47

Pelvic pseudotumoral calcium pyrophosphate dihydrate deposition: an ultrastructural study. J Rheumatol (1994) 1.46

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Ann Rheum Dis (2006) 1.45

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44

Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis. Arthritis Rheum (1997) 1.44

Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum (2001) 1.44

Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography. Rev Rhum Engl Ed (1998) 1.43

Prevalence of hepatitis G virus RNA in French blood donors and recipients. Transfusion (1997) 1.42

[Sjögren's syndrome. Relation to viral infections]. Presse Med (1993) 1.41

Granulocytic sarcoma (chloroma): imaging findings in adults and children. AJR Am J Roentgenol (2002) 1.41

Rheumatoid arthritis and bronchiectasis. A retrospective study of fourteen cases. Rev Rhum Engl Ed (1996) 1.40

Bilateral frozen shoulder at the same time in two brothers. Rev Rhum Engl Ed (1999) 1.40

Low-grade MALT lymphoma mimicking Waldenström's macroglobulinemia. Leukemia (1999) 1.38

Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update. J Intern Med (2008) 1.38

Polyarthritis with perinuclear antineutrophil cytoplasmic antibody inaugurating microscopic polyangiitis. Report of a case. Rev Rhum Engl Ed (1997) 1.38

Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur J Immunol (1999) 1.36

Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis (2004) 1.35

Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study. Ann Rheum Dis (2003) 1.32

Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum (2001) 1.30

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis (2009) 1.30

Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis (2004) 1.29

Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol (1996) 1.27

Radiologic progression in early rheumatoid arthritis treated with methotrexate. J Rheumatol (1999) 1.27

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) (2010) 1.25

Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome. Arterioscler Thromb Vasc Biol (2001) 1.25

Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol (1999) 1.25

Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome. Ann Rheum Dis (2005) 1.24

Factors associated with nursing-home entry for elders in Manitoba, Canada. J Gerontol A Biol Sci Med Sci (2000) 1.21

Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol (1996) 1.21

The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 1.21

Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis (2004) 1.18

Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol (1993) 1.17

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry. Ann Rheum Dis (2012) 1.16

Radiological damage in patients with rheumatoid arthritis on sustained remission. Ann Rheum Dis (2006) 1.16

Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum (2006) 1.14

The economics of lung cancer management in Canada. Lung Cancer (1996) 1.13

Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis (2011) 1.12

Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis (2006) 1.11

B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Scand J Immunol (2008) 1.11

High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol (2003) 1.09

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis (2012) 1.09

[Complete and dissociated forms of Poland's syndrome (5 cases)]. Rev Rhum Mal Osteoartic (1992) 1.09

Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Ann Rheum Dis (1997) 1.09

Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions. Eur J Cancer (2001) 1.08

Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis. Ann Rheum Dis (2000) 1.08

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe. Ann Rheum Dis (2009) 1.08

Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy. Ann Rheum Dis (2005) 1.08

Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesis. Am J Hum Genet (1993) 1.07

Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) (1999) 1.07

The Health Utility Index: measuring health differences in Ontario by socioeconomic status. Health Rep (1995) 1.07

Rheumatoid nodulosis: report of two new cases and discussion of diagnostic criteria. J Rheumatol (1988) 1.06

Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis (1999) 1.06

Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus. Ann Rheum Dis (2008) 1.03

Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis). Arthritis Rheum (2011) 1.03

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial. Arthritis Rheum (2012) 1.03

Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data. Ann Rheum Dis (2011) 1.01

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment. Clin Microbiol Infect (2007) 0.99

How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol (2005) 0.99

Eighteen cases of crowned dens syndrome: Presentation and diagnosis. Neurochirurgie (2013) 0.98

Diagnostic value of serum and synovial procalcitonin in acute arthritis: a prospective study of 42 patients. Clin Exp Rheumatol (2005) 0.97

Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1. J Am Soc Nephrol (1999) 0.97

Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients. Arthritis Rheum (1994) 0.97